SACRAMENTO, CA — Former Los Angeles Mayor and current California gubernatorial candidate Antonio Villaraigosa has publicly alleged that Kamala Harris and Xavier Becerra were involved in concealing former President Joe Biden’s mental and physical decline during his time in office.

Villaraigosa, a Democrat, made the claim amid a heated California gubernatorial race. Becerra, the former Secretary of Health and Human Services, is also a candidate, while speculation continues over a potential Harris bid. The race comes as current Governor Gavin Newsom reaches the end of his second and final term, per California’s two-term limit.

In a statement referencing recent reporting and excerpts from the book Original Sin, Villaraigosa stated:

“What I’ve seen in news coverage and excerpts from the new book ‘Original Sin’ is deeply troubling. At the highest levels of our government, those in power were intentionally complicit or told outright lies in a systematic cover up to keep Joe Biden’s mental decline from the public.”

Both Harris and Becerra previously served as California Attorney General. Villaraigosa emphasized their past leadership roles, stating:

“Now, we have come to learn this cover up includes two prominent California politicians who served as California Attorney General – one who is running for Governor and another who is thinking about running for Governor.”

He added:

“Those who were complicit in the cover up should take responsibility for the part they played in this debacle, hold themselves accountable, and apologize to the American people. I call on Kamala Harris and Xavier Becerra to do just that – and make themselves available to voters and the free press because there’s a lot of questions that need to be answered.”

Becerra responded in a statement, saying:

“It’s clear the President was getting older, but he made the mission clear: run the largest health agency in the world, expand care to millions more Americans than ever before, negotiate down the cost of prescription drugs, and pull us out of a world-wide pandemic. And we delivered.”

Kamala Harris has not issued a public response. Fox News Digital reported that it reached out to the offices of Harris and the Bidens but had not received a reply at the time of publication.

The allegations come as discussions about Biden’s cognitive and physical health continue. Earlier this month, during an appearance on The View, Biden dismissed claims of cognitive decline during his presidency.

In related developments, Biden’s personal office recently confirmed that he had been diagnosed with prostate cancer characterized by a high Gleason score and metastasis to the bone.

Villaraigosa’s comments are the latest in a growing list of concerns raised within the Democratic Party about leadership transparency and accountability in the final years of the Biden administration.

A newly released interim report from Senator Ron Johnson’s office claims top U.S. health officials in the Biden administration withheld critical information in early 2021 about potential heart-related side effects associated with mRNA COVID-19 vaccines. The 54-page report alleges that despite receiving multiple warnings about the risks—particularly cases of myocarditis and related conditions in young people—federal agencies delayed issuing formal alerts for several months.

According to the report, health officials at the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) were informed as early as February 2021 about international concerns, including an attempt by Israel’s Ministry of Health to raise alarm over roughly 40 myocarditis cases tied to the Pfizer vaccine. At that time, Israel’s vaccination campaign was further along than the U.S.’s, offering an early view of potential adverse effects.

In response to Israel’s outreach, FDA officials acknowledged limitations in existing data and asked for further information. However, despite growing domestic reports of heart inflammation—more than 158 cases by April—the agencies did not formally update the public until late June. The vaccine was nonetheless approved for adolescents in May.

By late May, internal deliberations began over whether to issue a Health Alert Network (HAN) message, which is typically used by the CDC to quickly notify clinicians and public health departments of emerging health threats. Some officials reportedly feared sounding “alarmist.” Others questioned whether the data truly warranted a full-scale warning. Ultimately, the HAN alert was shelved in favor of a more subdued website notice issued on May 28.

In the interim, internal talking points continued to describe the condition as rare and urged continued vaccination. The official FDA label for both the Pfizer and Moderna vaccines wasn’t updated to reflect the myocarditis risk until June 25.

The report, while critical, notes that many individuals who developed myocarditis, pericarditis, or myopericarditis after vaccination experienced a resolution of symptoms, a finding consistent with CDC data.

Senator Johnson, a frequent critic of the federal pandemic response, has argued that transparency was lacking during this period. “The full extent of the Biden administration’s failure to immediately warn the public about all COVID-19 vaccine adverse events must be completely exposed,” the report concludes.

Health officials involved in the decisions, including then-FDA commissioner Dr. Janet Woodcock and then-CDC director Dr. Rochelle Walensky, have not yet publicly responded to the findings in the interim report.

The release comes amid ongoing political scrutiny over pandemic-era decision-making and the future of public health communications in the wake of COVID-19. The Biden administration and health agencies have consistently maintained that the benefits of mRNA vaccines outweigh the risks, particularly during the height of the pandemic when COVID-19 posed a significant public health threat.

As investigations continue, Johnson’s subcommittee says it plans to further examine the internal communications and decision-making processes of the nation’s top health agencies.

The U.S. government has inadvertently sent at least $239 million to the Taliban in development assistance since 2021, according to a new report. The oversight occurred because the State Department failed to properly vet award recipients.

Less than a year after it was reported that the Taliban established fake nonprofits to siphon millions of dollars in U.S. aid to Afghanistan, a new investigation by the Special Inspector General for Afghanistan Reconstruction (SIGAR) reveals that the terrorist group has received hundreds of millions in development assistance due to inadequate vetting by the State Department. Since the 2021 U.S. military withdrawal, at least $239 million have likely filled the Taliban’s coffers.

The State Department’s divisions known as Democracy, Human Rights, and Labor (DRL) and International Narcotics and Law Enforcement Affairs (INL) disbursed the funds to implement development projects aimed at supporting American foreign policy and national security goals in Afghanistan.

Investigators found that the State Department failed to comply with its own counterterrorism partner vetting requirements before awarding at least 29 grants to various local entities. The agency has a system in place to identify whether prospective awardees have a record of ethical business practices and is supposed to conduct risk assessments to determine if programming funds may benefit terrorists or terrorist-affiliates before distributing American taxpayer dollars. However, in the more than two dozen cases examined, the agency neglected these procedures and failed to maintain proper records.

“Because DRL and INL could not demonstrate their compliance with State’s partner vetting requirements, there is an increased risk that terrorist and terrorist-affiliated individuals and entities may have illegally benefited from State spending in Afghanistan,” the SIGAR report states. “As State continues to spend U.S. taxpayer funds on programs intended to benefit the Afghan people, it is critical that State knows who is actually benefiting from this assistance in order to prevent the aid from being diverted to the Taliban or other sanctioned parties, and to enable policymakers and other oversight authorities to better scrutinize the risks posed by State’s spending.”

The watchdog identified issues with 29 awards distributed by DRL and INL. For instance, DRL failed to properly screen the recipients of seven awards totaling about $12 million. INL did not provide any supporting documentation for 19 of its 22 awards totaling about $295 million, making it impossible to determine if they complied with vetting requirements. The State Department acknowledged that not all its bureaus have complied with document retention requirements, complicating the assessment of the magnitude of its transgressions. INL cited “employee turnover and the dissolution of the Afghanistan-Pakistan office” as reasons for not retaining records.

Given the Taliban’s takeover of Afghanistan in August 2021, SIGAR emphasized the importance of U.S. government activities adhering to laws, regulations, and policies intended to prevent transactions with terrorists.

Besides establishing fraudulent non-governmental organizations (NGOs) to loot significant portions of the $3 billion in humanitarian aid the U.S. has provided Afghanistan since the Biden administration’s abrupt military withdrawal, the Taliban has also accrued millions by charging taxes, permit fees, and import duties. This money has flowed through the U.S. Agency for International Development (USAID), a State Department arm known for its corruption, which received $63.1 billion for foreign assistance and diplomatic engagement this year. Additionally, the U.S. Agency for Global Media (USAGM), the government’s international broadcasting service, also disbursed funds.

The United Nations has received $1.6 billion in U.S. funding for Afghanistan, and a significant percentage of that money likely went to the Taliban, according to a federal audit. The U.S. government does not require the UN to report on taxes, fees, or duties incurred on American funds for activities in Afghanistan, further complicating accountability.

SOURCE: SIGAR REPORT